Revenue recognition from Collaboration and License Agreements - Schedule of Revenue From Collaboration Agreements (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Collaboration agreements	$ 1,073	$ 30,249	$ 53,477	$ 35,927
Roche
Disaggregation of Revenue [Line Items]
Collaboration agreements	1,073	4,825	50,888	10,137
Bristol-Myers Squibb Company
Disaggregation of Revenue [Line Items]
Collaboration agreements	0	14,951	2,589	15,317
Ono Collaboration Agreement
Disaggregation of Revenue [Line Items]
Collaboration agreements	$ 0	$ 10,473	$ 0	$ 10,473